| 431 | 0 | 245 |
| 下载次数 | 被引频次 | 阅读次数 |
本研究以砂仁为原料,通过不同提取方式制备了6种不同规格的砂仁提取物,分析6种砂仁提取物主要有效成分含量的差异;并基于高通量筛选模型,通过体外酶活性检测,分析6种提取物对黄嘌呤氧化酶的抑制效果。结果表明,6种砂仁提取物中有效成分含量存在显著性差异(P<0.05),主要活性成分分别为总多糖、总多酚、总黄酮的砂仁提取物对黄嘌呤氧化酶均有抑制活性,砂仁总黄酮抑制活性最高。在一定浓度范围内砂仁提取物中总黄酮的含量与黄嘌呤氧化酶抑制活性呈正相关,当砂仁提取物(总黄酮≥50%)浓度达到0.8 mg/mL时,其对黄嘌呤氧化酶的抑制活性与阳性对照组别嘌呤醇基本相当,抑制率达到(98.98±0.13)%。研究结果为以砂仁药材为原料的降尿酸食品的开发和利用提供数据支撑。
Abstract:This study utilized Amomum villosum as the raw material to prepare six different specifications of extracts through various extraction methods. The differences in the content of main active components among the six extracts were analyzed. Based on a high-throughput screening model, the inhibitory effects of the six extracts on xanthine oxidase were evaluated through in vitro enzyme activity assays.The results indicated that there were significant differences(P<0.05) in the active component content among the six Amomum villosum extracts. The extracts primarily composed of total polysaccharides, total polyphenols, and total flavonoids all exhibited inhibitory activity against xanthine oxidase, with the total flavonoid extract demonstrating the highest inhibitory activity.Within a certain concentration range, the content of total flavonoids in the Amomum villosum extract showed a positive correlation with its xanthine oxidase inhibitory activity. When the concentration of the extract(total flavonoids ≥ 50%) reached 0.8 mg/m L, its inhibitory activity against xanthine oxidase was comparable to that of the positive control group(allopurinol), achieving an inhibition rate of(98.98 ± 0.13)%.The results provide a foundation for the development and utilization of Amomum villosum extract in functional food for uric acid reducing.
[1]古远聪,谭志豪,吕帮玉,等.砂仁的化学成分、药理活性及鉴别的研究进展[J].中国实验方剂学杂志,2024,30(22):270-278.
[2]周小妹,练勇,罗明权,等.海南砂仁化学成分及其胃黏膜保护活性研究[J].海南医科大学学报,2025,31(9):641-651.
[3]刘靓,姜晶,陈贝妮,等.春砂仁多糖对高脂饮食小鼠脂代谢和抗氧化作用的影响[J].中国食品添加剂,2024,35(3):163-170.
[4]曹冠华,张雪,陈月月,等.阳春砂仁叶和杆乙醇提取物抑菌作用的比较[J].中成药,2020,42(7):1914-1917.
[5]新华网.“00后”患者不断增多痛风为何“找上”年轻人[EB/OL].(2024-10-24)[2025-02-20]. https://news.cctv.cn/2024/10/24/ARTI9r5tc8a0ZNNUlHeJbxeC241024.shtml.
[6]魏晓慧,高莹,郁忠勤.痛风患者痛风发作对后续心血管事件的影响[J].中国当代医药,2024,31(22):32-36.
[7]Abhishek A,Tata L J,Mamas M,et al. Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink,from 1997 to across the COVID-19 pandemic in 2021[J]. Annals of the Rheumatic Diseases,2022,81(6):898-899.
[8]McCormick N,Choi H K. Racial disparities in the modern gout epidemic[J]. The Journal of Rheumatology,2022,49(5):443-446.
[9]任妮娜,凌益,马武开,等.基于虚、毒、瘀理论探讨痛风的发病机制[J/OL].辽宁中医杂志,2024:1-8.(2024-11-05). https://kns.cnki.net/KCMS/detail/detail.aspx?filename=L NZY2024110500B&dbname=CJFD&dbcode=CJFQ.
[10]王悠扬,张楚珩,黄晓明,等.降尿酸治疗初期不同措施预防痛风发作的成本效果分析[J].中华临床免疫和变态反应杂志,2024,18(4):349-357.
[11]潘爱平,靳晓萍,加孜热亚·再依拿提.非布司他联合吲哚美辛对痛风性关节炎患者血尿酸、疼痛程度及氧化应激水平的影响[J].疑难病杂志,2024,23(8):945-949.
[12]FitzGerald J D,Dalbeth N,Mikuls T,et al. 2020 American college of rheumatology guideline for the management of gout[J]. Arthritis Care&Research,2020,72(6):744-760.
[13]朱孟铸,赵广华.苍苓止痛合剂佐治痛风的临床研究[J].山东医学高等专科学校学报,2024,46(4):41-43.
[14]曾永长,梁少瑜,吴俊洪,等.基于病症模型的经方四妙丸防治高尿酸血症痛风的药效物质探讨[J].中药新药与临床药理,2024,35(8):1152-1162.
[15]杨倩,张志姣,刘新泳,等.具有治疗痛风性肾病潜力的天然产物研究进展[J].中国药物化学杂志,2024,34(3):224-240.
[16]El-Tantawy W H. Natural products for the management of hyperuricaemia and gout:A review[J]. Archives of Physiology and Biochemistry,2021,127(1):61-72.
[17]张继斌.砂仁药材的综合利用试验研究[J].农产品加工,2018,(17):13-15,18.
[18]韦志.海南砂仁活性成分研究及产品开发[D].南昌:南昌大学,2021.
[19]高林林,王倩,张竞雯,等.春砂仁和益智仁中黄酮类物质的精制及其抑菌和抗肿瘤功能研究[J].食品安全质量检测学报,2019,10(14):4659-4666.
[20]国家药典委员会.中华人民共和国药典-一部:2015年版[M].北京:中国医药科技出版社,2015:253-254.
[21]董群,郑丽伊,方积年.改良的苯酚-硫酸法测定多糖和寡糖含量的研究[J].中国药学杂志,1996,(9):38-41.
[22]王晨,邹宇晓,李倩,等.桑叶酚类物质组成及富集工艺研究[J].蚕业科学,2018,44(5):729-737.
[23]Feng S B,Song L X,Liu Y C,et al. Hypoglycemic activities of commonly-used traditional Chinese herbs[J]. The American Journal of Chinese Medicine,2013,41(4):849-864.
基本信息:
DOI:10.19804/j.issn1006-2513.2025.11.004
中图分类号:TS201.2
引用信息:
[1]彭婷,陈志元,赖富丽,等.砂仁提取物活性成分及其对黄嘌呤氧化酶抑制活性研究[J].中国食品添加剂,2025,36(11):26-31.DOI:10.19804/j.issn1006-2513.2025.11.004.
基金信息:
湖北省重点研发计划项目(2022ACA003-03-004); 黄石市揭榜制科技项目(2023A005)